68Ga-FAPI PET/CT通过检测直肠癌患者的第二原发恶性肿瘤改善治疗策略
68Ga-FAPI PET/CT显示双侧胸膜下结节低摄取,但左肺结节局灶性摄取增高,CT引导活检证实为原发性肺腺癌,最终诊断为直肠和肺双原发恶性肿瘤。
要点
- 68Ga-FAPI PET/CT可检测直肠癌患者的第二原发恶性肿瘤。
- FDG低摄取的双侧胸膜下结节经FAPI PET/CT评估为低摄取,活检证良性。
- FDG轻度摄取的左肺结节在FAPI PET/CT上局灶性摄取增高,活检证实为原发性肺腺癌。
核心结论
- 68Ga-FAPI PET/CT通过检测第二原发恶性肿瘤改善了该直肠癌患者的治疗策略。
主要发现
- 胸膜下结节活检诊断为良性病变。
- 68Ga-FAPI PET/CT显示双侧胸膜下结节低摄取,但左肺结节局灶性摄取增高。
- 左肺结节经CT引导活检证实为原发性肺腺癌,最终诊断为直肠和肺双原发恶性肿瘤。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A 71-year-old man with pathologically confirmed rectal cancer underwent F-FDG PET/CT before radical operation, which showed multiple nodules with low uptake in bilateral pleura and 1 solitary pulmonary nodule with slight uptake in left lung. The subpleural nodule was diagnosed as benign lesion through the biopsy. Ga-labeled fibroblast-activation-protein inhibitor PET/CT was performed for further evaluation, which showed low uptake in bilateral subpleural nodules but focally increased uptake in the nodule of left lung. This nodule was found to be a primary lung adenocarcinoma by the CT-guided biopsy. A diagnosis of rectum and lung double primary malignancies was finally made.
引用
- Chen H, Zhao L, Ruan D, et al. 68Ga-FAPI PET/CT Improves Therapeutic Strategy by Detecting a Second Primary Malignancy in a Patient With Rectal Cancer. Clin Nucl Med. 2020. PMID: 32149789. doi:10.1097/RLU.0000000000003000
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。